Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Cisco
CSCO
|
$493M |
| 2 |
Broadcom
AVGO
|
$327M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$324M |
| 4 |
iShares National Muni Bond ETF
MUB
|
$314M |
| 5 |
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
$302M |
Top Sells
| 1 |
SPDR Portfolio Short Term Treasury ETF
SPTS
|
$453M |
| 2 |
iShares MBS ETF
MBB
|
$438M |
| 3 |
AT&T
T
|
$279M |
| 4 |
SPDR S&P Global Natural Resources ETF
GNR
|
$172M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$155M |
Sector Composition
| 1 | Technology | 20% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Consumer Portfolio Services
CPSS
$177M
| $375K | ﹤0.01% |
+36,545
| New | +$375K |
|
3152
Vanguard International Dividend Appreciation ETF
VIGI
$8.55B
| $375K | ﹤0.01% |
5,464
-183
| -3% | -$12.6K |
|
3153
Dakota Gold
DC
$516M
| $374K | ﹤0.01% |
+111,602
| New | +$374K |
|
3154
Tenaya Therapeutics
TNYA
$228M
| $374K | ﹤0.01% |
66,338
-2,366
| -3% | -$13.3K |
|
|
JBIO
3155
Jade Biosciences, Inc. Common Stock
JBIO
$244M
| $373K | ﹤0.01% |
681
-258
| -27% | -$141K |
|
3156
Lifetime Brands
LCUT
$93.3M
| $373K | ﹤0.01% |
33,704
+824
| +3% | +$9.12K |
|
3157
ThredUp
TDUP
$1.37B
| $373K | ﹤0.01% |
149,040
+128,932
| +641% | +$323K |
|
|
CMLS
3158
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $372K | ﹤0.01% |
+48,027
| New | +$372K |
|
|
CNVY
3159
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $369K | ﹤0.01% |
35,449
+4,786
| +16% | +$49.8K |
|
3160
Crawford & Co Class A
CRD.A
$543M
| $367K | ﹤0.01% |
46,940
+10,215
| +28% | +$79.9K |
|
3161
Spire Global
SPIR
$278M
| $363K | ﹤0.01% |
39,115
+34,350
| +721% | +$319K |
|
3162
HighPeak Energy
HPK
$926M
| $361K | ﹤0.01% |
14,078
+2,113
| +18% | +$54.2K |
|
|
TIG
3163
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $361K | ﹤0.01% |
57,913
+17,109
| +42% | +$107K |
|
3164
Zeta Global
ZETA
$4.42B
| $353K | ﹤0.01% |
+77,879
| New | +$353K |
|
3165
Vanguard Growth ETF
VUG
$187B
| $351K | ﹤0.01% |
+1,575
| New | +$351K |
|
3166
Torrid Holdings
CURV
$164M
| $350K | ﹤0.01% |
80,984
-15,426
| -16% | -$66.7K |
|
3167
NextDecade
NEXT
$2.64B
| $347K | ﹤0.01% |
77,945
+67,936
| +679% | +$302K |
|
3168
Precision BioSciences
DTIL
$58.6M
| $346K | ﹤0.01% |
7,208
-4,874
| -40% | -$234K |
|
3169
Aterian
ATER
$9.66M
| $345K | ﹤0.01% |
13,283
+6,554
| +97% | +$170K |
|
3170
Nautilus Biotechnolgy
NAUT
$88.5M
| $342K | ﹤0.01% |
127,006
+104,750
| +471% | +$282K |
|
|
PSTX
3171
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $342K | ﹤0.01% |
132,419
-87,671
| -40% | -$226K |
|
|
ALPN
3172
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $339K | ﹤0.01% |
39,823
+7,406
| +23% | +$63K |
|
3173
Outlook Therapeutics
OTLK
$42M
| $338K | ﹤0.01% |
16,549
+714
| +5% | +$14.6K |
|
3174
Taysha Gene Therapies
TSHA
$884M
| $338K | ﹤0.01% |
90,711
-74,634
| -45% | -$278K |
|
|
EDR
3175
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $335K | ﹤0.01% |
16,242
+8,634
| +113% | +$178K |
|